COVID-19 News: International Updates 26th May

▴ covid19-news-international-updates-26th-may
Brazil supports HCQ and other international updates on COVID-19

Brazil supports HCQ though WHO suspends human trials

On Monday Brazil’s health ministry Brazil's health ministry said that it would not change its recommendation to treat Coronavirus with hydroxychloroquine, despite the World Health Organization issuing order to suspend trials of the drug over safety concerns.

Like US President Donald Trump, Brazilian President Jair Bolsonaro has supported the supposed benefits of hydroxychloroquine and a related drug, chloroquine, against the COVID-19 disease.

However, studies have shown that the drugs actually increased the risk of death due to the disease which resulted in WHO suspending a worldwide clinical trial of hydroxychloroquine as a COVID-19 treatment.

"We're remaining calm and there will be no change  to the Brazilian guideline issued last week” , health ministry official Mayra Pinheiro told a news conference.

Studies in China and France showed that the drugs hydroxychloroquine and chloroquine might be effective in battling the coronavirus disease which led to governments buying the drugs in bulk. Trump even said that he took hydroxychloroquine last week as a preventive measure and had completed his course of treatment on Sunday.

Questioning the authenticity of the studies which showed the harmful effects of the drugs Pinheiro said ,"It wasn't a clinical trial, it was just a data set collected from different countries, and that doesn't meet the criteria of a methodologically acceptable study to serve as a reference for any country in the world, including Brazil."

US death tally crosses 20,000 mark with 532 new deaths

The US death toll stands at 20000 with 532 new deaths on Saturday surpassing Italy for the highest in the world.
New York remains deep in crisis, while 24 residents of an Indiana nursing home hit by COVID-19 have died. Nursing homes in Iowa reported 14 deaths. Chicago's Cook County has set up a temporary morgue that can accommodate up to 2000 bodies.
The ourbreak’s centre of gravity has been shifting from China to Europe and now the United states, which as of now has the highest no. of confirmed cases and a death toll higher than that of Italy.

“Don’t do silly things,” said Domenico Arcuri, Italy’s special Commissioner for the virus emergency. “Don’t go out, continue to behave responsibly as you have done until today, use your head and your sense of responsibility.”

On Saturday New York reported 783 more deaths which increased the total no. of deaths to 8600. Gov. Andrew Cuomo said that the daily no. of deaths is stabilizing but stabilizing at a horrific rate.



 

Tags : #Brazil #Hydroxychloroquine #UnitedStates

Related Stories

02 Aug

Sweet Poison: Heavy Metal Contamination in Chocolate

While chocolates and cocoa-based products are generally safe to consume in moderation, it is essential to be aware of the potential risks associated with heavy metal contamination.

View
18 Mar

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy.

View
17 Nov

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need for broader insurance coverage to ensure accessibility for a larger population.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
03 Nov

A New Hope for Sickle Cell Patients: Groundbreaking Gene Therapy Under FDA Review

Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying the patient's blood cells, the therapy targets the root cause of the disease, promoting the production of healthy haemoglobin.

View
23 Oct

Indian Medtech Startup Sigtuple Receives U.S. FDA approval; becomes India's 1st company in this space to earn the clearance

For all haematological disorders like blood cancers, infections, anaemia & allergies, the microscopic examination of the peripheral blood smear (PBS) is the gold standard test, but microscopy today is predominantly a manual process - necessitating a highly skilled pathologist to be present on-site.

View
06 Oct

Safety Concerns Arise: FDA Investigates Probiotic-Related Infant Death

Probiotics are live microorganisms believed to enhance health when consumed adequately, while they offer potential health benefits, this incident highlights the importance of careful consideration, especially in vulnerable populations like preterm infants.

View
05 Aug

FDA Approves Groundbreaking Postpartum Depression Oral Pill - Zurzuvae (Zuranolone)

Postpartum depression (PPD) affects countless new mothers worldwide, casting a shadow over what should be a joyful time in their lives. For years, healthcare professionals have been searching for an effective treatment for this debilitating condition. In a momentous development, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever postpartum depression oral pill, Zurzuvae (Zuranolone).

View
23 Feb

4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029

Latest Pharma news

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025